Abstract

Nuclear receptor subfamily 2 group E member 1 (Nr2e1) has been regarded as an essential regulator of the growth of neural stem cells. However, its function elsewhere is unknown. In the present study, we generated Nr2e1 knockdown MIN6 cells and studied whether Nr2e1 knockdown affected basal beta cell functions such as proliferation, cell death, and insulin secretion. We showed that knockdown of Nr2e1 in MIN6 cells resulted in increased sensitivity to lipotoxicity, decreased proliferation, a partial G0/G1 cell-cycle arrest, and higher rates of apoptosis. Moreover, Nr2e1 deficiency exaggerates palmitate-induced impairment in insulin secretion. At the molecular level, Nr2e1 deficiency augments palmitate-induced oxidative stress. Nr2e1 deficiency also resulted in decreases in antioxidant enzymes and expression level of Nrf2. Together, this study indicated a potential protective effect of Nr2e1 on beta cells, which may serve as a target for the development of novel therapies for diabetes.

Highlights

  • In type 1 diabetes (T1D) beta cell mass is markedly reduced by autoimmune destruction

  • Type 2 diabetes (T2D) results from inadequate beta cell mass and function that can no longer compensate for insulin resistance

  • While type 1 diabetes clearly results from a loss of beta cells, the contribution of beta cell failure to type 2 diabetes is uncertain for decades [1]

Read more

Summary

Introduction

In type 1 diabetes (T1D) beta cell mass is markedly reduced by autoimmune destruction. Type 2 diabetes (T2D) results from inadequate beta cell mass and function that can no longer compensate for insulin resistance. Pancreatic islets usually respond by beta cell compensation, a process which involves both expansion of the beta cell mass and enhanced beta cell function to maintain normoglycemia [4,5,6]. Defects of this beta cell compensatory response trigger the onset of diabetic hyperglycemia. A more complete understanding of the mechanisms that control islet beta cell survival and function should provide new clues to develop more effective therapies for both major forms of diabetes

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call